GRAIL Company Description

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.

The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development.

In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

GRAIL, Inc.

Country	United States
Founded	2015
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	1,000
CEO	Robert Ragusa

Contact Details

Address: 1525 O’Brien Drive Menlo Park, Delaware 94025 United States
Phone	833-694-2553
Website	grail.com

Stock Details

Ticker Symbol	GRAL
Exchange	Mexican Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2835

Key Executives

Name	Position
Robert Ragusa	Chief Executive Officer
Aaron Freidin	Chief Financial Officer
Paul Ciccolella	Chief Operating Officer